about
Salinomycin as a drug for targeting human cancer stem cellsMitochondria, cholesterol and cancer cell metabolismChronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem CellsRepurposing metformin for cancer treatment: current clinical studiesMetformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-AnalysisNew promises for metformin: advances in the understanding of its mechanisms of actionChemoquiescence for ideal cancer treatment and prevention: where are we now?Advances in targeting signal transduction pathwaysHeterogeneity of glycolysis in cancers and therapeutic opportunities.Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancerMetabolic control of cancer cell stemness: Lessons from iPS cellsHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsXenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsLow concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer actionDo metformin a real anticarcinogen? A critical reappraisal of experimental data.The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.Autophagy, Warburg, and Warburg reverse effects in human cancer.The nutritional phenome of EMT-induced cancer stem-like cellsL1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control studyRas/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsMetformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.Clinical benefits of metformin in gynecologic oncology.Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosineThe first European interdisciplinary ewing sarcoma research summitMetformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells.Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary TumorigenesisMetformin and the promise of geroprotection
P2860
Q21285139-6110D9C5-5C79-4DE4-BDF7-BE66A6AF2138Q26741708-2A92D985-63D7-4B70-9D8F-32A6310828E1Q26752377-CE83A7A1-D68A-4CAB-B6FB-4D7369E033AEQ26752651-34CCE5BB-C0F6-4A88-9641-EB7C65E04B54Q26765139-3F314ADD-6A2E-4B1C-9CF0-5C40B2DF40D6Q27023545-BBB4BFDE-AD4B-4953-8480-2025ACCCDA9CQ27026391-9FF19601-AC85-4D76-B05D-1A87C41B928FQ27686983-3265CA74-AC26-48A2-AA24-51CC507B80B1Q27693375-FA978B24-5717-4A27-BE62-68E63065546BQ28066348-442358DB-C7B9-44F5-8279-D4FEDA911204Q28081608-D79228D3-DEB6-48BA-B7EE-3DB55DA7FDC7Q28393898-9095D5EA-A565-412C-8BFE-D985B76A2C92Q28395443-959E44B4-FAD2-413C-9987-344195467577Q28487772-B83CEF49-2F49-4D01-ABF5-42F8DA51E795Q30863461-4F33F886-49A3-40D0-B277-DB44D85604CFQ33566593-92470A98-9C94-4E5D-B610-1549ED4DCE65Q33605925-D76BFE30-7404-4024-9641-99D2ACE2BC9AQ33675285-A73D97F9-3BFA-43AA-8408-217CE8F083B9Q33751263-9208F522-DC43-4DED-BAD8-2CF1F2C83AB9Q33757043-1C21B922-8A3D-4BA9-8DB2-E045484FF141Q34092128-493DE9EC-E40D-4257-81CD-6AA18F9AB340Q34100815-F098AF84-5AD9-403B-B42F-F04FC6CDF751Q34305634-453CBF48-2A7B-4DAC-90E9-62E4206D84FFQ34307356-A0529462-FACE-45F0-936D-049C9133FF99Q34391710-F7163E4F-8264-4FE0-A345-7AAA960FDA0FQ34483548-EF0BABD6-5BA5-4CD7-93BE-4D9EE5FE59AEQ34483726-1BFDAF74-D37E-4A0E-AAEC-DCC2BCAB7A28Q35125031-4BC0E8B4-F6F6-441E-8E2F-FE4F316379DDQ35425337-D3E99E64-C7D5-43C4-8D1C-5E0DB3F97974Q35550204-4B56D98F-4DF5-41FA-A341-70D1F457E959Q35803926-1ACD8BCB-EB06-45D3-A21F-A2B0F31708F5Q35871269-6000EC1E-040B-427E-904A-0F5A1E762E5AQ35954892-90CE4CAC-6E8B-4507-BF60-59FE34D8D681Q35956368-58ED2291-F9B6-44DA-B6CF-902410112906Q35987417-AABA7598-1836-47E2-8FE3-023014351CA0Q35993560-4C646125-E2F6-4700-9CE5-43FC1E950556Q36021086-D20C41A7-A4DC-46CE-A476-07784CF81341Q36059702-DEA6D616-AA4C-44BB-B9EA-35CA1E7CF65BQ36078840-AE26A249-0D7F-4FB2-B3EB-9E38A831CE69Q36107738-C256C34D-E189-4923-877B-C998FD110113
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Metformin: multi-faceted protection against cancer.
@ast
Metformin: multi-faceted protection against cancer.
@en
type
label
Metformin: multi-faceted protection against cancer.
@ast
Metformin: multi-faceted protection against cancer.
@en
prefLabel
Metformin: multi-faceted protection against cancer.
@ast
Metformin: multi-faceted protection against cancer.
@en
P2093
P2860
P921
P356
P1433
P1476
Metformin: multi-faceted protection against cancer.
@en
P2093
Alejandro Vazquez-Martin
Cristina Oliveras-Ferraros
Javier A Menendez
Joaquim Bosch-Barrera
Jorge Joven
Sonia Del Barco
Sílvia Cufí
P2860
P304
P356
10.18632/ONCOTARGET.387
P407
P5008
P577
2011-12-01T00:00:00Z